04/15/2025
3:37 PM | Editas Medicine (Filer)
| Form ARS | |
04/04/2025
3:38 PM | Editas Medicine (Filer)
| Form PRE 14A | |
03/27/2025
3:41 PM | Editas Medicine (Issuer)
Lucera Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2025
3:33 PM | Burkly Linda (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2025
3:37 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2025
11:15 PM | Editas Medicine (Filer)
| Form EFFECT | |
03/20/2025
3:30 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
4:10 PM | Editas Medicine (Filer)
| Form POS AM | |
03/05/2025
3:43 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:44 PM | Editas Medicine (Issuer)
Lucera Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:06 PM | Editas Medicine (Filer)
| Form POSASR | |
Get the Latest News and Ratings for EDIT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. |
02/28/2025
3:35 PM | Burkly Linda (Reporting)
Editas Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
7:45 AM | Deep Track Capital, LP (Filed by)
Editas Medicine (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
8:03 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
3:17 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:37 PM | Editas Medicine (Issuer)
Mei Baisong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:40 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
1:30 PM | Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:57 AM | Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:36 AM | Editas Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:33 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
6:04 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
12:10 PM | Editas Medicine (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
09/06/2024
3:18 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:20 PM | Editas Medicine (Issuer)
Mei Baisong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:06 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
4:02 PM | Burkly Linda (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
4:01 PM | Editas Medicine (Issuer)
Mei Baisong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
6:23 PM | Editas Medicine (Subject)
Mei Baisong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
3:17 PM | Burkly Linda (Reporting)
Editas Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
5:28 AM | Editas Medicine (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
06/27/2024
4:02 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
5:04 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
4:11 PM | Editas Medicine (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:13 PM | Chatterjee Meeta (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:14 PM | Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:15 PM | Editas Medicine (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:30 PM | Editas Medicine (Issuer)
Reeve Emma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:30 PM | Editas Medicine (Issuer)
Lucera Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:32 PM | Editas Medicine (Subject)
Lucera Erick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
3:17 PM | Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon’s Terrifying Warning Forces Trump To Take Action (Ad) Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history.
Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are... Get your free gold guide! |
05/08/2024
3:21 PM | Editas Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:08 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy EDIT Stock Free EDIT Stock Alerts